Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies

Biochemistry, Genetics and Molecular Biology

• KRAS 100%
• Mutation 70%
• Signal Transduction 20%
• Cancer Cell 20%
• Apoptosis 20%
• Receptor Tyrosine Kinase 10%
• Oncogene 10%
• Cell Proliferation 10%
• Cell Aging 10%
• Cell Growth 10%
• Cell Cycle Arrest 10%
• Mammalian Target of Rapamycin 10%
• Biochemistry 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• Apoptosis 20%
• Protein Tyrosine Kinase 10%
• Monotherapy 10%
• Non Small Cell Lung Cancer 10%
• Cancer Growth 10%
• Malignant Neoplasm 10%
• Cell Cycle 10%
• Cell Proliferation 10%